Key facts
- This page summarizes Jayme Mendal's Form 4 filing for EverQuote, Inc. (EVER).
- 6 reported transactions and 2 derivative rows are listed below.
- Accepted by SEC: 04 Nov 2026, 17:45.
Key filing fact
Ownership activity is grounded in SEC Form 4 disclosures.
Shares, units, or other non-derivative securities reported in this filing.
Options Exercise
Sale
Sale
Options Exercise
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
Options Exercise
Options Exercise
Additional SEC filing notes
Rule 10b5-1 trading plan
These transactions were reported as open-market trades under a Rule 10b5-1 plan. The plan lets an insider set trading instructions in advance, which can reduce the risk of trading while in possession of material nonpublic information.
Original filing language: transaction made pursuant to a contract, instruction, or written plan intended to satisfy Rule 10b5-1(c).
Footnote F1
The option exercises and sale were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 16, 2026.
Footnote F2
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $23.22 to $24.21, inclusive. The reporting person undertakes to provide EverQuote, Inc., any security holder of EverQuote, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this Form 4.
Footnote F3
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $24.22 to $24.32, inclusive. The reporting person undertakes to provide EverQuote, Inc., any security holder of EverQuote, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this Form 4.
Footnote F4
The reporting person exercised this option outside of a Rule 10b5-1 trading plan and paid the exercise price in cash. The reporting person continues to hold all shares acquired upon exercise, and no shares were sold or withheld in connection with this exercise.
Footnote F5
This option was granted on October 18, 2017. 25% of the shares underlying the option vested on September 30, 2018, with the remaining shares vesting monthly thereafter over the following three years.